VGXI is a CDMO specializing in the production of plasmid DNA products with a proven track record of success in manufacturing challenging plasmid DNA products under cGMP conditions. The company was founded on technology for optimized, large-scale plasmid DNA purification. Based outside Houston, Texas, the company’s new 120,000-square-foot pDNA manufacturing headquarters is a cutting-edge facility purpose-built for contract development and manufacturing. Since its inception, VGXI has been dedicated to manufacturing GMP-compliant products for both clinical and commercial applications.